Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-162661
Filing Date
2017-05-08
Accepted
2017-05-08 16:31:08
Documents
2
Effectiveness Date
2017-05-08

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d389907d8k.htm DEFA14A 20992
2 EX-99.1 d389907dex991.htm EX-99.1 13356
  Complete submission text file 0001193125-17-162661.txt   35414
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36395 | Film No.: 17822875
SIC: 2834 Pharmaceutical Preparations